Links & Summaries of new Hepatitis C Articles

[Guest guest]

Boston-bound Vertex breaks ground on Fan Pier HQ

Boston Herald

The company, which is relocating its headquarters from Cambridge, finalized a

long-term lease with Fallon for 1.1 million square feet of office and lab space

after winning federal regulatory approval for its potential blockbuster

hepatitis C drug ...

See all stories on this topic »Ex-FrontPoint manager in talks with US on fraud

case

Pensions & Investments

Prosecutors claimed he obtained non-public information from Yves Benhamou, an

expert in hepatitis drugs and a former adviser for Human Genome Sciences. The

tips concerned hepatitis C drug trials and enabled FrontPoint to avoid more than

$30 million in ...

See all stories on this topic »Pharmasset Announces Issuance of U.S. Patent for

PSI-7977

PR Newswire (press release)

This patent generally relates to the composition of matter of PSI-7977 and its

diastereomeric mixture for the treatment of hepatitis C virus (HCV). PSI-7977, a

uracil nucleotide analogue polymerase inhibitor of HCV, is being studied in

multiple phase 2 ...

See all stories on this topic »

New Drugs Offer Hope For Hepatitis C Sufferers

NPR

In May, the FDA announced the approval of two new drugs that greatly raise the

success rate of treatment for hepatitis C virus type 1, the first major advance

in treatment for the virus in years. More than 3 million Americans are

chronically infected ...

See all stories on this topic »Drug Ups Response Rate in Refractory Hepatitis C

MedPage Today

The protease inhibitor, telaprevir (Incivek), markedly improved response rates

in patients with difficult-to-treat hepatitis C virus (HCV) infection, compared

with standard therapy, according to two studies reported in the June 23 issue of

the New ...

See all stories on this topic »NEJM study: New drug represents breakthrough in

treatment of hepatitis C

EurekAlert (press release)

NEW YORK (June 23, 2011) -- The drug telaprevir (Incivek) provides a dramatic

improvement in the treatment of the most common form of hepatitis C infection,

says an international team of investigators led by Dr. Ira M. son of

NewYork-Presbyterian ...

See all stories on this topic »Allman Brothers Band Return To Beacon Theatre

UGO

By Greg Prato 12 hours ago Since 1991, the Allman Brothers Band has performed at

New York's famed Beacon Theatre every single year...expect for 2007, when the

group's longtime leader, Gregg Allman, was too ill from chronic hepatitis C to

perform. ...

See all stories on this topic »

UGOMedivir: TMC649128 enters Phase Ib Trial in Patients Chronically Infected

with ...

MarketWatch (press release)

Medivir AB (sto:MVIRB)(omx:MVIR), the emerging research-based specialty

pharmaceutical company focused on infectious diseases, today announces the start

of a phase Ib clinical trial with TMC649128 intended for the treatment of

chronic hepatitis C virus ...

See all stories on this topic »